Deutsche Bank Ag\ Morpho Sys Ag Transaction History

Deutsche Bank Ag\

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$21.56 - $30.66 $123,711 - $175,927	-5,738 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.81 - $30.33 $130,872 - $159,990	5,275 Added 1139.31%	5,738 $163,000
Q3 2020 Nov 12, 2020	SELL	$30.28 - $35.72 $300,165 - $354,092	-9,913 Reduced 95.54%	463 $15,000
Q2 2020 Aug 13, 2020	BUY	$24.08 - $33.35 $249,854 - $346,039	10,376 New	10,376 $329,000
Q1 2020 May 14, 2020	SELL	$18.86 - $37.36 $54,712 - $108,381	-2,901 Closed	0 $0

Q4 2019 Feb 14, 2020	SELL	$26.07 - $36.32 $254,964 - $355,209	-9,780 Reduced 77.12%	2,901 $103,000
Q3 2019 Nov 14, 2019	BUY	$24.18 - $31.58 $305,441 - $398,918	12,632 Added 25779.59%	12,681 $348,000
Q2 2019 Aug 14, 2019	BUY	$23.24 - $26.76 $1,138 - $1,311	49 New	49 $1,000
Q4 2018 Feb 14, 2019	SELL	$21.96 - $31.02 $2,196 - $3,102	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$26.64 - $35.66 $2,664 - $3,565	100 New	100 $2,000

11.3M

320K

1.1M

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.54B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.